Li Kang Biomedical Stock Shares Owned By Insiders
| 6242 Stock | TWD 43.40 0.60 1.36% |
Li Kang Biomedical fundamentals help investors to digest information that contributes to Li Kang's financial success or failures. It also enables traders to predict the movement of 6242 Stock. The fundamental analysis module provides a way to measure Li Kang's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Li Kang stock.
6242 |
Li Kang Biomedical Company Shares Owned By Insiders Analysis
Li Kang's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Li Kang Shares Owned By Insiders | 72.30 % |
Most of Li Kang's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Li Kang Biomedical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 72% of Li Kang Biomedical are shares owned by insiders. This is much higher than that of the Personal Products sector and significantly higher than that of the Consumer Staples industry. The shares owned by insiders for all Taiwan stocks is notably lower than that of the firm.
6242 Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Li Kang's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Li Kang could also be used in its relative valuation, which is a method of valuing Li Kang by comparing valuation metrics of similar companies.Li Kang is currently under evaluation in shares owned by insiders category among its peers.
6242 Fundamentals
| Return On Equity | 0.19 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 1.05 B | |||
| Shares Outstanding | 23.31 M | |||
| Shares Owned By Insiders | 72.30 % | |||
| Price To Earning | 15.32 X | |||
| Price To Book | 2.30 X | |||
| Price To Sales | 1.94 X | |||
| Revenue | 386.97 M | |||
| Gross Profit | 264.68 M | |||
| EBITDA | 76.83 M | |||
| Net Income | 51.44 M | |||
| Cash And Equivalents | 187.44 M | |||
| Cash Per Share | 8.04 X | |||
| Total Debt | 24.59 M | |||
| Debt To Equity | 0.06 % | |||
| Current Ratio | 2.56 X | |||
| Book Value Per Share | 23.12 X | |||
| Cash Flow From Operations | 60.45 M | |||
| Earnings Per Share | 4.16 X | |||
| Number Of Employees | 123 | |||
| Beta | 0.47 | |||
| Market Capitalization | 1.37 B | |||
| Total Asset | 616.07 M | |||
| Z Score | 33.0 | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 616.07 M | |||
| Last Dividend Paid | 1.43 |
About Li Kang Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Li Kang Biomedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Li Kang using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Li Kang Biomedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Li Kang
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Li Kang position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Li Kang will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Li Kang could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Li Kang when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Li Kang - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Li Kang Biomedical to buy it.
The correlation of Li Kang is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Li Kang moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Li Kang Biomedical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Li Kang can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for 6242 Stock Analysis
When running Li Kang's price analysis, check to measure Li Kang's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Li Kang is operating at the current time. Most of Li Kang's value examination focuses on studying past and present price action to predict the probability of Li Kang's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Li Kang's price. Additionally, you may evaluate how the addition of Li Kang to your portfolios can decrease your overall portfolio volatility.